2NCH

Solution structure of translation initiation factor IF1 from wolbachia endosymbiont strain TRS of Brugia malayi

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5-1.0 mM [U-100% 15N] IF1-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.1 % sodium azide-4, 2 mM PMSF-5	95% H2O/5% D2O	50	6.5	ambient	298
2	3D HNCO	0.8-1.0 mM [U-100% 13C; U-100% 15N] IF1-6, 20 mM sodium phosphate-7, 50 mM sodium chloride-8, 0.1 % sodium azide-9, 2 mM PMSF-10	95% H2O/5% D2O	50	6.5	ambient	298
3	3D CBCA(CO)NH	0.8-1.0 mM [U-100% 13C; U-100% 15N] IF1-6, 20 mM sodium phosphate-7, 50 mM sodium chloride-8, 0.1 % sodium azide-9, 2 mM PMSF-10	95% H2O/5% D2O	50	6.5	ambient	298
4	3D HNCACB	0.8-1.0 mM [U-100% 13C; U-100% 15N] IF1-6, 20 mM sodium phosphate-7, 50 mM sodium chloride-8, 0.1 % sodium azide-9, 2 mM PMSF-10	95% H2O/5% D2O	50	6.5	ambient	298
5	3D HN(CA)CO	0.8-1.0 mM [U-100% 13C; U-100% 15N] IF1-6, 20 mM sodium phosphate-7, 50 mM sodium chloride-8, 0.1 % sodium azide-9, 2 mM PMSF-10	95% H2O/5% D2O	50	6.5	ambient	298
6	2D 1H-13C HSQC aliphatic	1.0 mM [U-100% 13C; U-100% 15N] IF1-11, 20 mM sodium phosphate-12, 50 mM sodium chloride-13, 0.1 % sodium azide-14, 2 mM PMSF-15	100% D2O	50	6.5	ambient	298
7	2D 1H-13C HSQC aromatic	1.0 mM [U-100% 13C; U-100% 15N] IF1-11, 20 mM sodium phosphate-12, 50 mM sodium chloride-13, 0.1 % sodium azide-14, 2 mM PMSF-15	100% D2O	50	6.5	ambient	298
8	3D 1H-15N NOESY	0.5-1.0 mM [U-100% 15N] IF1-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.1 % sodium azide-4, 2 mM PMSF-5	95% H2O/5% D2O	50	6.5	ambient	298
9	3D 1H-13C NOESY aliphatic	1.0 mM [U-100% 13C; U-100% 15N] IF1-11, 20 mM sodium phosphate-12, 50 mM sodium chloride-13, 0.1 % sodium azide-14, 2 mM PMSF-15	100% D2O	50	6.5	ambient	298
10	3D 1H-13C NOESY aromatic	1.0 mM [U-100% 13C; U-100% 15N] IF1-11, 20 mM sodium phosphate-12, 50 mM sodium chloride-13, 0.1 % sodium azide-14, 2 mM PMSF-15	100% D2O	50	6.5	ambient	298
11	3D 1H-15N TOCSY	0.5-1.0 mM [U-100% 15N] IF1-1, 20 mM sodium phosphate-2, 50 mM sodium chloride-3, 0.1 % sodium azide-4, 2 mM PMSF-5	95% H2O/5% D2O	50	6.5	ambient	298
12	3D C(CO)NH	0.8-1.0 mM [U-100% 13C; U-100% 15N] IF1-6, 20 mM sodium phosphate-7, 50 mM sodium chloride-8, 0.1 % sodium azide-9, 2 mM PMSF-10	95% H2O/5% D2O	50	6.5	ambient	298
13	3D H(CCO)NH	0.8-1.0 mM [U-100% 13C; U-100% 15N] IF1-6, 20 mM sodium phosphate-7, 50 mM sodium chloride-8, 0.1 % sodium azide-9, 2 mM PMSF-10	95% H2O/5% D2O	50	6.5	ambient	298
14	3D HCCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] IF1-11, 20 mM sodium phosphate-12, 50 mM sodium chloride-13, 0.1 % sodium azide-14, 2 mM PMSF-15	100% D2O	50	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
molecular dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
2	validation	PSVS		Bhattacharya and Montelione
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.